Nervous Disorder TRIZ Cases

Intranasal YB-1 protein reduces beta-amyloid levels and enhances neuronal density, addressing incurable disease progression in Alzheimer's therapy.

Anti-DEspR antibody therapy reduces survival of hyperactivated neutrophils, mitigating hyperinflammation and organ dysfunction in COVID-19 patients.

Segmented liposomes display targeted peptides to boost immunogenicity, addressing the lack of approved vaccines for neurodegenerative diseases.

A transdermal patch uses an adhesive layer with isopropyl palmitate to enhance skin permeability of asenapine.

Measuring specific clusterin isoforms in blood plasma resolves the trade-off between diagnostic accuracy and sample invasiveness.

EvoScore algorithm analyzes blood biomarkers to distinguish epileptic events from non-epileptic conditions.

Selective COMT inhibitors increase cortical dopamine concentration to improve cognitive function in psychiatric disorders.

A subcutaneous anti-Aβ protofibril antibody formulation delivers therapeutic doses via injection.

AARS protein fragments modulate extracellular signaling pathways for therapeutic and diagnostic applications.

Culturing umbilical cord mesenchymal stem cells with platelet-derived growth factor BB enhances insulin-like growth factor 1 receptor levels.

Imidazole-poly(organophosphazene) hydrogel fills cystic cavities via sol-gel transition.

Mixed gamma-hydroxybutyrate salts reduce sodium intake while maintaining therapeutic efficacy for narcolepsy treatment.

Phosphate derivatives of fractalkine receptor antagonists improve aqueous solubility to reduce liver stress during first-pass metabolism.

Thrombin-treated stem cell exosomes deliver neuroprotective factors to treat neonatal hypoxic ischemic encephalopathy.

Terminal acetylation and amidation extend peptide half-life in serum, enabling pancreatic islet regeneration.

Hyaluronidase degrades tissue barriers to improve immune globulin absorption, resolving the trade-off between storage stability and bioavailability.

Substituting arginine 409 with lysine and modifying CH2/CH3 domains reduces aggregate formation at low pH while maintaining antigen-binding ability.

Copper-containing articles release ions to treat sleep apnea, avoiding mechanical side effects and improving long-term patient compliance.

Segmented bicyclic thiazine derivatives target BACE1 specifically, reducing amyloid-beta plaque formation without retinal damage.

A carboxyl-terminal growth hormone fragment peptide promotes chondrocyte and muscle tissue repair.

Segmented antibody fragments block CCK-B receptors to relieve pain without opioid addiction risks.

Branched octanoic acid derivatives inhibit AMPA receptors, providing seizure control without the metabolic burden of ketogenic diets.

A phyto-medicament composition blends Garcinia kola, pomegranate, and Moringa oleifera to alleviate anxiety symptoms.

Liposomes accumulate in macrophages to transport pharmaceutical agents across the blood-brain barrier, reducing systemic side effects from high dosing.

Daily Lactobacillus fermentum GKF3 administration lowers urine nicotine metabolites, reducing tobacco addiction without triggering withdrawal symptoms.

Fibroblast compositions suppress autoreactive T cells and induce remyelination, addressing side effects of conventional immunosuppressive drugs.

A G-CSF dimer increases dopamine levels and protects dopaminergic neurons in neurodegenerative disease models.

Cannabidiolic acid addresses inadequate ASD treatments by reversing behavioral symptoms and improving cognition without severe side effects.

Recombinant NMDAR antibodies enable specific detection of anti-NMDAR antibodies in biological samples.

Redox-active tripeptides detoxify peroxidase activity and reduce oxidative stress without the toxicity of traditional small molecule inhibitors.

VTFT-BPIFB4 activates CXCR4 receptors to enhance mitochondrial function and reduce protein aggregation in neuronal diseases.

Peptides under 2000 Da modulate aquaporin 4 via specific organic and azido moieties, avoiding off-target receptor interactions.

Engineered antibodies detect human c-Met expression in cancer cells, resolving cross-reactivity with RON receptors to improve diagnostic reliability.

Homotriglyceride MCT-C8 and C10 compositions increase ketone concentrations in bodily fluids.

Oxidized polyisobutylene intermediary prevents rivastigmine-adhesive interactions that cause skin irritation.

Non-racemic modified release formulations reduce blood plasma peaks and QT interval prolongation while maintaining dopamine D2 receptor occupancy.

Anti-CCR7 antigen binding proteins block CCL19 and CCL21 binding, providing effective inhibition where current therapies fail.

Dimethylaminoethanol modulates the septo-hippocampal cholinergic pathway to enhance memory performance in patients with mild cognitive impairment.

Composite Aβ vaccine with CpG adjuvants achieves 100% antibody response, resolving weak immunogenicity in Alzheimer's treatment.

DPP4 inhibitors restore GABAergic transmission to treat cognitive deficits without triggering convulsions.

Response classifier computes signal detection metrics to quantify cognitive abilities from user interactions with computerized tasks.

Droxidopa converts to norepinephrine via dopa decarboxylase, treating neurally mediated hypotension without trial-and-error drug combinations.

Heating transforms monomers to dimers, raising efficacy while reducing odor and intake volume.

Lactococcus lactis SL131 enhances synaptic plasticity, offering a safe alternative to medications that cause safety concerns in pregnant women and children.